Filing Details

Accession Number:
0001235802-18-000181
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-11 16:27:15
Reporting Period:
2018-12-11
Accepted Time:
2018-12-11 16:27:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401040 Diamedica Therapeutics Inc. DMAC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1759855 T. James Parsons 2 Carlson Parkway
Suite 260
Minneapolis MN 55447
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Shares, No Par Value Per Share Acquisiton 2018-12-11 2,250 $4.00 6,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.